PROKIDNEY CORP. — Investor Relations & Filings
Filings indexed
371
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
US
United States of America
Listing
US
PROK
ProKidney Corp. is a late clinical-stage biotechnology company developing a proprietary, first-in-class cell therapy platform for the treatment of advanced Chronic Kidney Disease (CKD). Its lead investigational candidate, rilparencel, is an autologous therapy derived from a patient's own kidney cells, which are obtained via a standard biopsy. The therapeutic approach aims to preserve remaining kidney function. Rilparencel is being evaluated for its potential to slow disease progression, with the goal of delaying or eliminating the need for dialysis in patients with limited treatment options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q | 2026-05-15 | English | |
| ARS - PROKIDNEY CORP. (0001850270) (Filer) | 2026-04-17 | English | |
| S-8 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | |
| 8-K - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | |
| 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 46358303 | 8-K | 2026-05-15 | English | ||
| 46358349 | 10-Q | 2026-05-15 | English | ||
| 34662031 | ARS - PROKIDNEY CORP. (0001850270) (Filer) | 2026-04-17 | English | ||
| 32979112 | S-8 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | ||
| 32979308 | 8-K - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | ||
| 32899780 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899781 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899782 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899783 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32063872 | 8-K Filing | 2026-02-02 | English | ||
| 13404633 | 8-K | 2026-01-12 | English | ||
|
2025
4 filings
| |||||
| 13404634 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 13404629 | 4 | 2025-11-14 | English | ||
| 13404630 | Regulatory Filings 2025 | 2025-11-12 | English | ||
| 13404631 | Regulatory Filings 2025 | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
PROKIDNEY CORP. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32485/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32485 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32485 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32485 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32485}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PROKIDNEY CORP. (id: 32485)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.